Quantitative evaluation for effect of iron supplementation therapy on erythropoiesis efficiency in hemodialysis patients treated with rHuEPO
Not Applicable
- Conditions
- Maintenance hemodialysis/ Renal anemia
- Registration Number
- JPRN-UMIN000020700
- Lead Sponsor
- Yokohama National University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients with chronic inflammation, malignant disorder, severe congestive heart failure, respiratory organs, and liver disorder (2) Patients who are receiving dialysis modalities other than hemodialysis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method (1) Hemoglobin and erythropoiesis-related indexes (2)Blood chemical examination including iron-related, inflammation, nutrition indexes (3)Required dose of rHuEPO (4)Hemodynamic parameters (1)-(4): Two-month after the start of iron administration.
- Secondary Outcome Measures
Name Time Method